These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35596897)

  • 1. Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.
    Yamazaki A; Arai Y; Fukuoka K; Nakano Y; Hama N; Nakata S; Makino K; Kuroda JI; Shinojima N; Mukasa A; Mikami Y; Ichimura K; Shibata T; Yokoo H; Nobusawa S
    Brain Tumor Pathol; 2022 Jul; 39(3):171-178. PubMed ID: 35596897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.
    Barresi V; Cardoni A; Miele E; Pedace L; Masotto B; Nardini C; Barresi S; Rossi S
    Acta Neuropathol Commun; 2024 Jan; 12(1):8. PubMed ID: 38216991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
    Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
    Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
    Pisapia DJ; Ohara K; Bareja R; Wilkes DC; Hissong E; Croyle JA; Kim JH; Saab J; MacDonald TY; Beg S; O'Reilly C; Kudman S; Rubin MA; Elemento O; Sboner A; Greenfield J; Mosquera JM
    Acta Neuropathol Commun; 2020 Jun; 8(1):80. PubMed ID: 32493417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report.
    Sugino H; Satomi K; Mori T; Mukai Y; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Yoshida A
    Brain Tumor Pathol; 2023 Apr; 40(2):133-141. PubMed ID: 36811792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1.
    Kao YC; Sung YS; Zhang L; Chen CL; Huang SC; Antonescu CR
    Genes Chromosomes Cancer; 2017 Jan; 56(1):42-50. PubMed ID: 27537276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
    Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
    Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
    [No Abstract]   [Full Text] [Related]  

  • 11. CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
    Tauziède-Espariat A; Uro-Coste E; Sievers P; Nicaise Y; Mariet C; Siegfried A; Pierron G; Guillemot D; Benzakoun J; Pallud J; Roques M; Bonneville F; Larrieu-Ciron D; Chaynes P; Saffroy R; Hamelin J; Hasty L; Métais A; Chrétien F; Kool M; Gojo J; Varlet P;
    Acta Neuropathol Commun; 2023 Feb; 11(1):26. PubMed ID: 36782314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
    Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.
    Muthukumarana V; Fix DJ; Stolnicu S; Park KJ; Soslow RA; Benayed R; Ladanyi M; Antonescu CR; Chiang S
    Am J Surg Pathol; 2020 Jun; 44(6):765-770. PubMed ID: 32011345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
    Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene of the month: BCOR.
    Aldera AP; Govender D
    J Clin Pathol; 2020 Jun; 73(6):314-317. PubMed ID: 32161069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarifying the impact of polycomb complex component disruption in human cancers.
    Yamamoto Y; Abe A; Emi N
    Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCOR gene alterations in hematologic diseases.
    Sportoletti P; Sorcini D; Falini B
    Blood; 2021 Dec; 138(24):2455-2468. PubMed ID: 33945606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
    Cen YX; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2004-2010. PubMed ID: 33283733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
    Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.